Product Information
ENSKYCE 28 TABLET is a generic product labeled by Lupin Pharmaceuticals Inc., priced at $0.1353 per EA under NDC 68180073973. Its NADAC has been published 86 times since Feb 12, 2025.
FDA first approved this application on Mar 7, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Lupin Pharmaceuticals Inc.NDC
68180073973
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA201887FDA Approved
3/7/2013
TE Code
AB
On Market Since
12/10/2024
Price Statistics
The NADAC for ENSKYCE 28 TABLET has been published 86 times since Feb 12, 2025, and over the history we have for it it has risen 12.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1353 per EA |
|---|---|
| All-time high | $0.1544 (Nov 12, 2025) |
| All-time low | $0.1207 (Feb 12, 2025) |
| 52-week high | $0.1544 |
| 52-week low | $0.1299 |
| Median price | $0.1440 |
| Average price | $0.1424 |
| Largest weekly change | +11.8% (Feb 19, 2025) |
| Weeks tracked | 86 |
| Tracking since | Feb 12, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lupin Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
desogestrel and ethinyl estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ENSKYCE 28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ENSKYCE 28 TABLET, manufactured by Lupin Pharmaceuticals Inc., is $0.1353 per EA (NDC 68180073973), effective Sep 30, 2026.
How has the price of ENSKYCE 28 TABLET changed over time?
Over the history we have for it, the NADAC for ENSKYCE 28 TABLET has risen 12.1%. It has been tracked across 86 weekly CMS publications since Feb 12, 2025.
What are the highest and lowest recorded NADAC prices for ENSKYCE 28 TABLET?
Since Feb 12, 2025, the NADAC for ENSKYCE 28 TABLET has ranged from a low of $0.1207 (Feb 12, 2025) to a high of $0.1544 (Nov 12, 2025), with a median of $0.1440 per EA.
Are there cheaper alternatives to ENSKYCE 28 TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ENSKYCE 28 TABLET, is $0.1217 per EA — about 10% below ENSKYCE 28 TABLET.
Who manufactures ENSKYCE 28 TABLET?
ENSKYCE 28 TABLET (NDC 68180073973) is labeled by Lupin Pharmaceuticals Inc., and CMS classifies it as a generic product.